Ying Wang   
Assistant Professor

Fellow, Cheng Yu Tung College


Academic Qualifications | Teaching | Research | Selected Publications | Qualifications | Contact Details

Academic Qualifications

  • B.Sc., Jilin University and Shenyang Pharmaceutical University, China
  • Ph.D., The University of Hong Kong, HK
  • Postdoctoral training, Yale University, USA



BIOB310       Pharmacology

BIOB311       Pharmacology – Laboratory

BIOB316       Cell Biology

CMED703     Introduction to Research in Chinese Medicinal Science

CMED800     Research Method

CMED803     System Pharmacology


Research Interests

  • Anti-inflammation and anti-liver cancer drug development
  • Chemical biology of natural product and derivatives
  • Immunopharmacology

We are looking for young talents who are interested in our research projects on drug discovery and molecular pharmacology to join us. For further details, please contact Dr. Wang at emilyywang@umac.mo

Selected Publications (*corresponding author; # equal contribution)


[1]     Min Li, Ling-Xiao Chen, Shao-Ru Chen, Yong Deng, Jing Zhao, Ying Wang*, Shao-Ping Li*. Nonstarch polysaccharide from Chinese yam activated Toll-like receptor 4 (TLR4)-NF-κB signaling in RAW 264.7 macrophage cells. Journal of Functional Foods, 2017, In print.


[2]     Ying Wang, Sangwon Lee, Ya Ha, Wing Lam, Shao-Ru Chen, Ginger E. Dutschman, Elizabeth A. Gullen, Susan P. Grill, Yao Cheng, Alois Fürstner, Samson Francis, David C. Baker, Xiaoming Yang, Kuo-Hsiung Lee, and Yung-Chi Cheng*. Tylophorine analogs allosterically regulates heat shock cognate protein 70 and inhibits hepatitis C virus replication. Scientific Reports, 2017, in print.


[3]   Tianshu Xu, Tianlei Ying, Lili Wang, Xiaohua Douglas Zhang, Ying Wang, Lishan Kang, Tao Huang, Liang Cheng, Liping Wang, Qi Zhao. A native-like bispecific antibody suppresses the inflammatory cytokine response by simultaneously neutralizing tumor necrosis factor-alpha and interleukin-17A. Oncotarget, 2017, in print.


[4]   Bao-Jian Guo, Zhao-Xiang Bian, Hong-Cong Qiu, Yitao Wang, Ying Wang*. Biological and clinical implications of herbal medicine and natural products: a concise review. Annals of the New York Academy of Sciences, 2017, in print.


[5]   Xin-Nie, Shao-Ru Chen, Kun Wang, Yuran Peng, Yitao Wang, Decai Wang, Ying Wang*, Guo-Chun Zhou*. Attenuation of innate immunity by andrographolide derivatives through NF-κB signaling pathway. Scientific Reports, 7: 4738, 2017.


[6]   Lie-Jun Huang#, Shao-Ru Chen#, Chun-Mao Yuan, Wei Gu, Bao-Jian Guo, Yi-Tao Wang, Ying Wang*, Xiao-Jiang Hao*. C21-steroidal pregnane sapogenins and their derivatives as anti-inflammatory agents. Bioorganic & Medicinal Chemistry, 25: 3512-3524, 2017.


[7]   Min-Li, Yi-Xi Yan, Qing-Tao Yu, Yong Deng, Ding-Tao Wu, Ying Wang, Ya-Zhong Ge, Shao-Ping Li*, Jing Zhao*. Comparison of immunomodulatory effects of fresh garlic and black garlic polysaccharides on RAW 264.7 macrophages. Journal of Food Science, 82: 765-771, 2017.  


[8]   Ying Wang, Wing Lam, Shao-Ru Chen, Fulan-Guan, Ginger Dutchman, Samson Francis, David Baker, Yung-Chi Cheng*. Tylophorine analog DCB-3503 inhibited cyclin D1 translation through allosteric regulation of heat shock cognate protein 70. Scientific Reports, 6: 32832, 2016.


[9]   Shao-Ru Chen, An-Qi Wang, Hong-Cong Qiu, Li-Gen Lin, Yi-Tao Wang*, Ying Wang*. Novel anti-hepatitis C virus activity of Spatholobus Suberectus. Molecules, 21: 1367, 2016.


[10] Xuenong Zhang, Wenwen Zhao, Ying Wang, Jinjian Lu, Xiuping Chen*. The chemical constituents and bioactivities of Psoralea corylifolia Linn.: a review. American Journal of Chinese Medicine, 44: 35, 2016.


[11] Shao-Ru Chen, Hong-Cong Qiu, Yang Hu, Ying Wang*, Yi-Tao Wang*. Herbal medicine offered as an initiative therapeutic option for the management of hepatocellular carcinoma. Phytotherapy Research, 30: 863, 2016.


[12] Shao-Ru Chen, Xiu-Ping Chen, Jin-Jian Lu, Ying Wang*, Yi-Tao Wang*. Implications of natural product and herbal medicine for the treatment of liver fibrosis. Chinese Medicine, 10: 7, 2015.


[13] Ying Wang*, Qing-Yu He, Jen-Fu Chiu*. Dioscin induced activation of p38 MAPK and JNK via mitochondrial pathway in HL-60 cell line. European Journal of Pharmacology, 735: 52, 2014.


[14] Ying Wang, Hui-Chyn Wong, Elizabeth A. Gullen, Wing Lam, Xiaoming Yang, Qian Shi, Kuo-Hsiung Lee, Yung-Chi Cheng*. Cryptopleurine analogs with modification of E ring exhibit different mechanism to Rac-cryptopleurine and tylophorine. PLoS ONE, 7: e51138, 2012.


[15] Ying Wang, Wenli Gao, Yuri V. Svitkin, Annie Pei-Chun Chen, Yung-Chi Cheng*. DCB-3503, a tylophorine analog, inhibits protein synthesis through a novel mechanism. PLoS ONE, 5: e11607, 2010.


[16] Ying Wang, Qing-Yu He, Sai-Wah Tsao, Yim-Hing Cheung, Anita Wong, Jen-Fu Chiu*. Cytokeratin 8 silencing in human nasopharyngeal carcinoma cells leads to cisplatin sensitization. Cancer Letters, 265: 188, 2008.


[17] Chi-Chun Wong, Ying Wang, Jen-Fu Chiu, Qing-Yu He*, Feng Chen*. Comparative proteomic analysis of indioside D-triggered cell death in HeLa cells. Journal of Proteome Research, 8: 2420, 2008.


[18] Ying Wang, Qing-Yu He, Chi-Ming Che, Sai Wah Tsao, Raymond Wai-Yin Sun, Jen-Fu Chiu*. Modulation of gold(III) porphyrin 1a-induced apoptosis by mitogen-activated protein kinase signaling pathways. Biochemical Pharmacology, 75: 1282, 2008.


[19] Ying Wang, Jen-Fu Chiu*. Proteomic approaches in understanding action mechanisms of metal-based anticancer drugs. Metal Based Drugs, 2008: 716329, 2008.


[20] Andy T.Y. Lau#, Ying Wang#, Jen-Fu Chiu*. Reactive oxygen species: current knowledge and applications in cancer research and therapeutic. Journal of Cellular Biochemistry, 104: 657-667, 2008. (# co-first author)


[21] Ying Wang, Jen-Fu Chiu, Qing-Yu He*. Isolation of cytoplasmic proteins from cultured cells for two-dimensional gel electrophoresis. 2D PAGE: Sample Preparation and Fractionation. Methods in Molecular Biology, 425: 101-112, 2008.


[22] Ying Wang, Chi-Ming Che, Jen-Fu Chiu, Qing-Yu He*. Dioscin (saponin)-induced generation of reactive oxygen species through mitochondria dysfunction: a proteomic-based study. Journal of Proteome Research, 6: 4703, 2007.


[23] Ying Wang, Qing-Yu He, Hongmin Chen, Jen-Fu Chiu*. Synergistic effects of retinoic acid and tamoxifen on human breast cancer cells: proteomic characterization. Experimental Cell Research, 313: 357, 2007.


[24] Ying Wang, Qing-Yu He, Raymond Wai-Yin Sun, Chi-Ming Che*, Jen-Fu Chiu*. Cellular pharmacological properties of gold(III) porphyrin 1a, a potential anticancer drug lead. European Journal of Pharmacology, 554: 113, 2007.


[25] Ying Wang, Yim Hing Cheung, Zhiqi Yang, Jen-Fu Chiu, Chi-Ming Che*, Qing-Yu He*. Proteomic approach to study the cytotoxicity of dioscin (saponin). Proteomics, 6: 2422, 2006.


[26] Ying Wang, Qing-Yu He, Chi-Ming Che*, Jen-Fu Chiu*. Proteomic characterization of the cytotoxic mechanism of gold(III) porphyrin 1a, a potential anticancer drug. Proteomics, 6: 131, 2006.


[27] Ying Wang, Jen-Fu Chiu, Qing-Yu He*. Proteomics approach to illustrate drug action mechanisms. Current Drug Discovery Technologies, 3: 199-209, 2006.


[28] Ying Wang, Qing-Yu He, Raymond Wai-Yin Sun, Chi-Ming Che*, Jen-Fu Chiu*. Gold(III) porphyrin 1a induced apoptosis by mitochondrial death pathways related to reactive oxygen species.  Cancer Research, 65: 11553, 2005.





Ÿ   The Consortium for Globalization of Chinese Medicine                 Member

Contact Details

Institute of Chinese Medical Sciences
University of Macau
Macao, China

Room 7010, N22 Research Building
Telephone: (853) 8822-4673
Fax: (853) 2884-1358
E-mail: emilyywang@umac.mo